Vertex Pharma Stock Price (NASDAQ:VRTX)

Add to My Stocks
$161.97 $4.14 (2.49%) VRTX stock closing price Jul 25, 2017 (Closing)
Prev Close* : $166.11
Market Cap:
$41.37B
Day Low: $161.72
52 Week Low: $71.46
Open: $166.94
Volume: 2424136
Day High: $167.86
52 Week High: $167.86
Dividend:
N/A

Latest Stock Market News

Latest Articles

Vertex Pharma News - From Partners

Top Stock Picks for the Week of July 24th   by Zacks on Jul 25, 2017

VRTX Stockcharts

View VRTX PE ratio, PS ratio stocks charts and compare with peers.
VRTX Chart
Note: Compare Vertex Pharma stock price history with the index and industry peers.

Vertex Pharma Valuation

PE ratio
(price earnings ratio)
234.74
PS ratio (
price to sales ratio
)
19.74
PB ratio (
price to book ratio
)
30.59

Vertex Pharma Returns

ROE
(return on equity)
13%

Vertex Pharma Financial Ratios

Asset Turnover
0.98
Receivables Turnover
10.49
Debt to Equity
0.03

VRTX Industry Peers

Company Price Change (%)
Biogen Inc (BIIB)282.961.74 (0.61%)
Regeneron Pharma (REGN)513.457.77 (1.49%)
Johnson & Johnson (JNJ)131.881.13 (0.85%)
Alpine Immune (ALPN)9.60.2 (2.13%)
Proqr Therapeutics (PRQR)5.250.14 (2.74%)
Galapagos (GLPG)81.760.78 (0.96%)
Ptc Therapeutics (PTCT)21.150.4 (1.86%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Compugen (CGEN)4.050.65 (19.12%)
Idera Pharma (IDRA)2.060.14 (7.29%)
Merrimack Pharma (MACK)1.360.05 (3.82%)
PDL BioPharma (PDLI)2.460.08 (3.36%)
Horizon Pharma (HZNP)13.480.32 (2.43%)
Keryx Biopharma (KERX)7.450.16 (2.19%)
Acorda Therapeutics (ACOR)22.850.45 (2.01%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jul 26, 2017
CompanyPriceChange (%)
Novavax (NVAX)1.10.41 (27.15%)
Dynavax Technologies (DVAX)9.90.75 (7.04%)
Vital Therapies (VTL)2.650.15 (5.36%)
EXACT Sciences (EXAS)37.332.11 (5.35%)
China Biologic Products (CBPO)98.325.05 (4.89%)
Epizyme (EPZM)12.650.65 (4.89%)
Trevena (TRVN)2.820.14 (4.73%)
Top losers from Medical-Biomed-Genetics industry
* As of Jul 26, 2017

Vertex Pharmaceuticals Incorporated Stock News - Partner Headlines

Vertex Pharma Financial Statements

income statement20162015201420132012
Net Sales Or Revenues1.7B1.03B580.41M1.21B1.53B
Net Income-112.05M-556.33M-738.55M-445.02M-107.03M
Total Operating Expense1.48B1.37B1.21B1.99B1.24B
view Vertex Pharmaceuticals Incorporated income statement
balance sheet20162015201420132012
Total Assets2.9B2.5B2.33B2.32B2.76B
Total Liabilities1.56B1.41B1.24B962.63M1.56B
Shareholders Equity1.34B1.09B1.1B1.36B1.2B
view Vertex Pharmaceuticals Incorporated balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-2.07M-85.94M-11.06M-5.05M-13.78M
Net Cash From (Used By) Operating Activities236.1M-365.43M-513.19M-51.57M267.84M
Increase (Decrease) In Prop Plant And Equipment-56.56M-45.3M-51.2M-51.39M-71.14M
view Vertex Pharmaceuticals Incorporated cashflow statement

Vertex Pharma Stock Message Board

Vertex Pharma stock price ended the last trading day at 161.97. The total market value as denoted by 41.37B for Vertex Pharma, is the market value of the company's outstanding shares. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Vertex Pharma stock analysis.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Vertex Pharma is worth a lot, it will most likely be reflected in an inflated Vertex Pharma stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. The volume number in Vertex Pharma stock quote data shows the number of shares traded. For Ex: 2424136 Vertex Pharma shares were traded as of last trading day, as seen from Vertex Pharma stock chart. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Vertex Pharma stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.